Factors that motivate men who have sex with men in Berlin, Germany, to use or consider using HIV pre-exposure prophylaxis-A multi-methods analysis of data from a multicentre survey.

Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Original Publication: San Francisco, CA : Public Library of Science

HIV Infections/*prevention & control ; HIV Infections/*psychology ; Homosexuality, Male/*psychology ; Homosexuality, Male/*statistics & numerical data ; Motivation/*physiology ; Pre-Exposure Prophylaxis/*statistics & numerical data; Berlin ; Cross-Sectional Studies ; Humans ; Male ; Mental Health/statistics & numerical data ; Quality of Life/psychology ; Sexual Behavior/psychology ; Sexual Behavior/statistics & numerical data ; Surveys and Questionnaires

Background: While our knowledge of what motivates men who have sex with men (MSM) to use HIV pre-exposure prophylaxis (PrEP) has grown in recent years, quantitative survey-based studies have not asked MSM explicitly to name their motivations. We did so using a qualitative open-ended question and aimed to categorise the responses and explore whether these were related to where MSM were located along a conceptual continuum of PrEP care.
Methods: In a multicentre survey examining knowledge and use of PrEP among MSM in Berlin, Germany, we additionally asked an open-ended question about motivations for using or considering PrEP. Data were collected from 10/2017-04/2018. One researcher developed a thematic framework deductively from the literature and another did so inductively from the free-text data, and a merged framework was used to code responses independently. We used Fisher's exact test to assess whether the frequency of motivations differed significantly between respondents using or considering PrEP.
Results: Of 875 questionnaires, 473 were returned and 228 contained a free-text response. Motivations in the following categories were reported: (1) Safety/protection against HIV (80.2% of participants, including general safety; additional protection to condoms), (2) Mental well-being and quality of life (23.5%, including reduced anxiety; better quality of life), (3) Condom attitudes (18.9% intent not to use condoms), (4) Expectations about sexuality (14.4%, including worry-free sex or more pleasurable sex, with explicit mention of sex or sexuality), (5) Norms/social perspectives (0.8%). The difference in frequencies of motivations between those using or considering PrEP was not statistically significant.
Conclusions: Safety and protection against HIV, particularly having additional protection if condoms fail, were the most common motivations for using or considering PrEP, followed by mental well-being and quality of life. Many respondents reported several motivations, and responses overall were heterogeneous. This suggests that approaches to increase PrEP uptake that focus exclusively on its effectiveness in preventing HIV are unlikely to be as successful as a holistic approach that emphasises multiple motivations and how these fit into the broader sexual and psychological health of MSM.
Competing Interests: The authors have declared that no competing interests exist.

Clin Infect Dis. 2014 Mar;58(5):704-12. (PMID: 24319083)
AIDS Behav. 2018 Aug;22(8):2640-2649. (PMID: 29582199)
Am J Public Health. 2019 Sep;109(9):1216-1223. (PMID: 31318587)
Lancet. 2016 Jan 2;387(10013):53-60. (PMID: 26364263)
Lancet HIV. 2019 Feb;6(2):e67. (PMID: 30686720)
Lancet Infect Dis. 2014 Sep;14(9):820-9. (PMID: 25065857)
AIDS Behav. 2018 Nov;22(11):3681-3691. (PMID: 29872999)
AIDS. 2016 Nov 28;30(18):2753-2756. (PMID: 27824624)
Psychol Bull. 1990 Nov;108(3):339-62. (PMID: 2270232)
Clin Infect Dis. 2015 Nov 15;61(10):1601-3. (PMID: 26334052)
JAMA Pediatr. 2017 Nov 1;171(11):1063-1071. (PMID: 28873128)
HIV Med. 2021 Jan;22(1):67-72. (PMID: 33021049)
PLoS One. 2018 Sep 13;13(9):e0204067. (PMID: 30212547)
J Acquir Immune Defic Syndr. 2019 Feb 1;80(2):e23-e29. (PMID: 30422909)
Nat Hum Behav. 2018 Aug;2(8):573-580. (PMID: 31209312)
J Virus Erad. 2017 Oct 1;3(4):218-222. (PMID: 29057086)
Front Med (Lausanne). 2021 Aug 25;8:722247. (PMID: 34513883)
J Int AIDS Soc. 2016 Jun 13;19(1):20903. (PMID: 27302837)
Eur J Public Health. 2020 Oct 1;30(5):967-973. (PMID: 32363377)
N Engl J Med. 2010 Dec 30;363(27):2587-99. (PMID: 21091279)
AIDS Behav. 2017 May;21(5):1236-1246. (PMID: 28108878)
AIDS Behav. 2008 Sep;12(5):713-20. (PMID: 17985229)
Lancet. 2020 Mar 28;395(10229):1025. (PMID: 32222189)
BMC Public Health. 2017 Dec 19;17(1):968. (PMID: 29258455)
BMC Med Res Methodol. 2013 Sep 18;13:117. (PMID: 24047204)
AIDS Behav. 2016 Jul;20(7):1400-7. (PMID: 26538056)
J Acquir Immune Defic Syndr. 2013 Apr 1;62(4):447-56. (PMID: 24135734)
Curr HIV/AIDS Rep. 2018 Apr;15(2):190-197. (PMID: 29460223)
Lancet HIV. 2017 Sep;4(9):e402-e410. (PMID: 28747274)
Ann Epidemiol. 2018 Dec;28(12):850-857.e9. (PMID: 29941379)
Arch Sex Behav. 2014 May;43(4):745-53. (PMID: 24729135)
Lancet HIV. 2018 Mar;5(3):e136-e145. (PMID: 29467098)
AIDS Care. 2021 Jan;33(1):92-100. (PMID: 32207327)
AIDS Behav. 2021 Feb;25(2):582-591. (PMID: 32886220)
J Acquir Immune Defic Syndr. 2016 Dec 15;73(5):540-546. (PMID: 27851714)
Adv Ther. 2020 May;37(5):1778-1811. (PMID: 32232664)
J Acquir Immune Defic Syndr. 2017 Jan 1;74(1):21-29. (PMID: 27632233)
J Clin Nurs. 2018 Sep;27(17-18):3254-3265. (PMID: 28771856)
Ann Behav Med. 2015 Apr;49(2):177-86. (PMID: 25124457)
PLoS One. 2016 Apr 19;11(4):e0151385. (PMID: 27093430)
BMC Psychiatry. 2008 Aug 18;8:70. (PMID: 18706118)
J Gen Intern Med. 2017 Jan;32(1):62-70. (PMID: 27778215)
J Acquir Immune Defic Syndr. 2017 Mar 1;74(3):285-292. (PMID: 28187084)
J Int AIDS Soc. 2018 Nov;21(11):e25211. (PMID: 30474351)
AIDS. 2017 Mar 13;31(5):731-734. (PMID: 28060019)
Sex Transm Infect. 2019 Jun;95(4):262-266. (PMID: 30833366)
AIDS Behav. 2017 May;21(5):1229-1235. (PMID: 26143247)
AIDS. 2018 Feb 20;32(4):523-530. (PMID: 29239887)
Front Public Health. 2020 Jul 14;8:298. (PMID: 32760688)
AIDS Behav. 1999 Dec;3(4):269-276. (PMID: 18568093)
J Acquir Immune Defic Syndr. 2017 Apr 15;74(5):531-538. (PMID: 27861236)
Med Anthropol. 2018 Jul;37(5):387-400. (PMID: 29257911)
AIDS Behav. 2018 Nov;22(11):3603-3616. (PMID: 29557540)
J Acquir Immune Defic Syndr. 2020 Feb 1;83(2):119-125. (PMID: 31935203)
AIDS Behav. 2017 May;21(5):1299-1308. (PMID: 27990587)
AIDS Behav. 2017 May;21(5):1325-1335. (PMID: 27900502)
BMC Public Health. 2019 Jan 28;19(1):120. (PMID: 30691426)
AIDS. 2017 Jul 31;31(12):1709-1714. (PMID: 28700394)
N Engl J Med. 2015 Dec 3;373(23):2237-46. (PMID: 26624850)
LGBT Health. 2014 Sep;1(3):218-24. (PMID: 26789715)
PLoS Med. 2014 Mar 04;11(3):e1001613. (PMID: 24595035)
J Adolesc Health. 2011 Aug;49(2):115-23. (PMID: 21783042)
AIDS Behav. 2019 Jul;23(7):1708-1720. (PMID: 30306439)
AIDS Educ Prev. 2015 Apr;27(2):112-25. (PMID: 25915697)
Am J Mens Health. 2018 Nov;12(6):1843-1854. (PMID: 30160195)
Clin Infect Dis. 2015 Nov 15;61(10):1590-7. (PMID: 26270691)
Euro Surveill. 2019 Oct;24(41):. (PMID: 31615599)
Lancet HIV. 2017 Nov;4(11):e482-e483. (PMID: 29066095)
Arch Suicide Res. 2015;19(2):131-50. (PMID: 25297459)
JAMA Intern Med. 2016 Jan;176(1):75-84. (PMID: 26571482)
Am J Public Health. 2015 Oct;105(10):1960-4. (PMID: 26270298)
Ann Epidemiol. 2018 Dec;28(12):833-840. (PMID: 30037634)
AIDS Behav. 2018 Apr;22(4):1139-1149. (PMID: 29143163)
AIDS Behav. 2014 Feb;18(2):195-216. (PMID: 23897125)
J Int AIDS Soc. 2017 Apr 6;20(1):21472. (PMID: 28418232)
Health Soc Work. 2021 May 10;46(1):22-32. (PMID: 33637990)
J Acquir Immune Defic Syndr. 2021 Apr 15;86(5):536-543. (PMID: 33399311)
AIDS Patient Care STDS. 2015 Jul;29(7):408-17. (PMID: 26057304)
AIDS Behav. 2020 Nov;24(11):3056-3070. (PMID: 32274670)
JAMA. 2019 Apr 9;321(14):1380-1390. (PMID: 30964528)

Date Created: 20211118 Date Completed: 20220107 Latest Revision: 20231103

20240829

PMC8601504

10.1371/journal.pone.0260168

34793575